Filing Details

Accession Number:
0001415889-13-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-07 12:23:29
Reporting Period:
2012-12-28
Filing Date:
2013-01-07
Filing Date Changed:
2013-01-07
Accepted Time:
2013-01-07 12:23:29
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374328 Bond Laboratories, Inc. BNLB.OB Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247604 T Jason Adelman Cipher Capital Partners C/o Rothschild
1251 Avenue Of The Americas, Suite 936
New York NY 10020
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Acquisiton 2012-12-28 4,202,260 $0.00 12,971,808
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date
Common Stock Warrant $0.30 2012-11-15
Common Stock Series C Convertible Preferred Stock $0.00 2012-11-15
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-11-15 667,083 667,083 Direct
1,334,000 1,334,000 Direct
Footnotes
  1. The Reporting Person acquired the shares of Issuer's common stock ("Common Stock") for aggregate consideration of $50,000 in a privately negotiated transaction.
  2. The Warrant contains a provision preventing the exercise of the Warrant if, as a result of such exercise, the Reporting Person would beneficially own, together with all other shares of Common Stock beneficially owned by the Reporting Person, in excess of 9.99% of the Issuer's Common Stock issued and outstanding.
  3. Each share of Series C Convertible Preferred Stock ("Series C Preferred") is convertible into 40,000 shares of Common Stock.
  4. The Series C Preferred is perpetual.
  5. The Certificate of Designations, Preferences and Rights of the Series C Preferred contains a provision preventing the conversion of the Series C Preferred if, as a result of such conversion, the Reporting Person would beneficially own, together with all other shares of Common Stock beneficially owned by the Reporting Person, in excess of 4.99% of the Issuer's Common Stock issued and outstanding.
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Billionaire Hedge Funds
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!